Manifestation of lipopolysaccharide-induced tolerance in neuro-glial primary cultures of the rat afferent somatosensory system.
Cytokines
Inflammation
Inflammatory pain
Inflammatory transcription factors
LPS tolerance
Mixed neuro-glial cultures
Journal
Inflammation research : official journal of the European Histamine Research Society ... [et al.]
ISSN: 1420-908X
Titre abrégé: Inflamm Res
Pays: Switzerland
ID NLM: 9508160
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
18
11
2020
accepted:
28
01
2021
revised:
12
01
2021
pubmed:
15
2
2021
medline:
6
11
2021
entrez:
14
2
2021
Statut:
ppublish
Résumé
Bacterial lipopolysaccharide (LPS) may contribute to the manifestation of inflammatory pain within structures of the afferent somatosensory system. LPS can induce a state of refractoriness to its own effects termed LPS tolerance. We employed primary neuro-glial cultures from rat dorsal root ganglia (DRG) and the superficial dorsal horn (SDH) of the spinal cord, mainly including the substantia gelatinosa to establish and characterize a model of LPS tolerance within these structures. Tolerance was induced by pre-treatment of both cultures with 1 µg/ml LPS for 18 h, followed by a short-term stimulation with a higher LPS dose (10 µg/ml for 2 h). Cultures treated with solvent were used as controls. Cells from DRG or SDH were investigated by means of RT-PCR (expression of inflammatory genes) and immunocytochemistry (translocation of inflammatory transcription factors into nuclei of cells from both cultures). Supernatants from both cultures were assayed for tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) by highly sensitive bioassays. At the mRNA-level, pre-treatment with 1 µg/ml LPS caused reduced expression of TNF-α and enhanced IL-10/TNF-α expression ratios in both cultures upon subsequent stimulation with 10 µg/ml LPS, i.e. LPS tolerance. SDH cultures further showed reduced release of TNF-α into the supernatants and attenuated TNF-α immunoreactivity in microglial cells. In the state of LPS tolerance macrophages from DRG and microglial cells from SDH showed reduced LPS-induced nuclear translocation of the inflammatory transcription factors NFκB and NF-IL6. Nuclear immunoreactivity of the IL-6-activated transcription factor STAT3 was further reduced in neurons from DRG and astrocytes from SDH in LPS tolerant cultures. A state of LPS tolerance can be induced in primary cultures from the afferent somatosensory system, which is characterized by a down-regulation of pro-inflammatory mediators. Thus, this model can be applied to study the effects of LPS tolerance at the cellular level, for example possible modifications of neuronal reactivity patterns upon inflammatory stimulation.
Identifiants
pubmed: 33582876
doi: 10.1007/s00011-021-01440-7
pii: 10.1007/s00011-021-01440-7
pmc: PMC8012319
doi:
Substances chimiques
CCAAT-Enhancer-Binding Protein-beta
0
Cytokines
0
Lipopolysaccharides
0
NF-kappa B
0
STAT3 Transcription Factor
0
Stat3 protein, rat
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
429-444Références
J Immunol. 1969 Dec;103(6):1223-36
pubmed: 4902894
Ann N Y Acad Sci. 1998 Sep 29;856:116-131
pubmed: 9917872
J Immunol. 2006 Dec 1;177(11):7880-8
pubmed: 17114459
Cell. 2002 Jul 26;110(2):191-202
pubmed: 12150927
Front Mol Neurosci. 2019 Dec 12;12:307
pubmed: 31920538
Curr Neuropharmacol. 2006 Jul;4(3):197-206
pubmed: 18615146
Brain Behav Immun. 2021 Jan;91:451-471
pubmed: 33157258
Biochim Biophys Acta. 1999 Jun 8;1450(2):130-44
pubmed: 10354505
Neuroscience. 2018 Dec 1;394:1-13
pubmed: 30342197
Trends Immunol. 2009 Oct;30(10):475-87
pubmed: 19781994
Innate Immun. 2012 Jun;18(3):541-59
pubmed: 22042912
J Neurosci Res. 2006 Apr;83(5):711-30
pubmed: 16541438
Mol Med. 2008 Jan-Feb;14(1-2):64-78
pubmed: 18026569
J Cell Physiol. 2019 Feb;234(2):1889-1903
pubmed: 30054903
Neuron. 2002 Sep 26;36(1):57-68
pubmed: 12367506
J Biol Chem. 2011 Mar 11;286(10):7905-7916
pubmed: 21220427
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
J Leukoc Biol. 2012 May;91(5):721-7
pubmed: 22389313
Pain. 2018 Oct;159(10):1908-1915
pubmed: 29889119
Immunobiology. 1997 Dec;198(1-3):81-90
pubmed: 9442380
J Infect Dis. 1999 Jan;179(1):279-82
pubmed: 9841855
Neuropharmacology. 2020 Oct 1;176:108227
pubmed: 32634527
Eur J Immunol. 2012 Jun;42(6):1449-58
pubmed: 22622800
J Immunol. 2000 Apr 1;164(7):3476-9
pubmed: 10725699
Nat Med. 2015 Aug;21(8):927-31
pubmed: 26193341
Mol Neurobiol. 2016 Dec;53(10):6950-6967
pubmed: 26666666
Brain Res. 2003 Aug 1;980(1):151-5
pubmed: 12865171
EMBO J. 2005 Dec 21;24(24):4211-23
pubmed: 16319926
J Immunol. 2000 Aug 1;165(3):1612-7
pubmed: 10903771
J Neuroinflammation. 2019 Feb 14;16(1):39
pubmed: 30764851
Front Immunol. 2019 Nov 08;10:2492
pubmed: 31781091
Crit Care. 2013 Nov 14;17(6):242
pubmed: 24229432
J Inflamm. 1995;45(1):56-63
pubmed: 7583353
Curr Biol. 2017 Feb 20;27(4):R129-R133
pubmed: 28222285
Cytokine Growth Factor Rev. 2000 Sep;11(3):199-207
pubmed: 10817963
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
J Gen Physiol. 2006 Nov;128(5):509-22
pubmed: 17074976
Leukemia. 1996 Aug;10(8):1308-16
pubmed: 8709636
Neurosci Lett. 2015 Jun 15;597:159-63
pubmed: 25912777
Pflugers Arch. 2020 Dec;472(12):1769-1782
pubmed: 33098464
J Leukoc Biol. 1997 Jan;61(1):88-95
pubmed: 9000541
Pflugers Arch. 2014 Jul;466(7):1451-66
pubmed: 24114176
J Immunol. 1991 Jun 1;146(11):3824-30
pubmed: 1903414
Infect Immun. 1999 May;67(5):2153-9
pubmed: 10225868
J Neuroimmunol. 2008 Nov 15;204(1-2):66-74
pubmed: 18786731
J Cell Biochem. 2019 Jan;120(1):56-70
pubmed: 30246452
Cytokine Growth Factor Rev. 2016 Oct;31:1-15
pubmed: 27185365
J Neurosci. 2009 Oct 28;29(43):13473-83
pubmed: 19864560
Brain Behav Immun. 2015 Aug;48:147-64
pubmed: 25813145
Nat Med. 2010 Nov;16(11):1258-66
pubmed: 20948531
J Basic Clin Physiol Pharmacol. 2020 Feb 20;31(4):
pubmed: 32078575
J Leukoc Biol. 2011 Dec;90(6):1141-8
pubmed: 21934070
Annu Rev Neurosci. 2001;24:487-517
pubmed: 11283319
J Biol Chem. 1994 Jun 24;269(25):17001-4
pubmed: 7516328
Crit Care Med. 2002 Jan;30(1 Suppl):S64-73
pubmed: 11782563
Scand J Pain. 2017 Oct;17:287-293
pubmed: 29229214
Eur J Immunol. 2017 Jul;47(7):1181-1187
pubmed: 28508449
J Leukoc Biol. 2017 Jan;101(1):107-119
pubmed: 27780875
Neuroscience. 2016 Jan 28;313:23-35
pubmed: 26608124
Eur J Pain. 2013 Sep;17(8):1180-8
pubmed: 23553993
Nat Med. 2018 Jul;24(7):1024-1035
pubmed: 29892069
Front Public Health. 2016 Oct 05;4:216
pubmed: 27761434
Cold Spring Harb Symp Quant Biol. 2013;78:69-79
pubmed: 25028399
Pain. 2015 Jun;156(6):1124-1144
pubmed: 25775359
Cytokine. 2010 Jan;49(1):102-8
pubmed: 19948415
Neuron. 2015 Aug 5;87(3):474-91
pubmed: 26247858